In rheumatoid arthritis progression, silencing SOCS1 has been reported to promote cell proliferation and invasion, upregulate IL-1β and MMP expression, and activate the ERK pathway to alleviate synovial tissue damage [12]. The gene discussed is IL1B; the disease is rheumatoid arthritis.